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Abstract Mutations at codons 717 and 670/671 in the 
amyloid precursor protein (APP) are rare genetic causes 
of familial Alzheimer’s disease (AD). A mutation at 
codon 693 of APP has also been described as the genetic 
defect in hereditary cerebral hemorrhage with amyloido-
sis of the Dutch type (HCHWA-D). We have reported a 
APP692Ala→ Gly (Flemish) mutation as a cause of in-
tracerebral hemorrhage and presenile dementia diagnosed 
as probable AD in a Dutch family. We now describe the 
post-mortem examination of two demented patients with 
the APP692 mutation. The neuropathological findings sup-
port the diagnosis of AD. Leptomeningial and parenchy-
mal vessels showed extensive deposition of Aβ amyloid 
protein. Numerous senile plaques consisted of large Aβ 
amyloid cores, often measuring more than 30 µ m in di-
ameter and were surrounded by a fine meshwork of dys-
trophic neurites. In addition, there were a large number of 
paired helical filaments in pyramidal neurons and dys-
trophic neurites. Our findings show that the APP692 mu-
tation leads to morphological abnormalities that are simi-
lar to AD, but the morphology of senile plaques is clearly 
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distinct from that described in sporadic and chromosome 
14-linked AD patients, in patients with APP717 mutations 
causing familial, presenile AD and in patients with the 
APP693 mutation causing HCHWA-D. 
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Introduction 
Alzheimer’s disease (AD) is a progressive dementia that 
is characterized by the presence of neurofibrillary tangles 
and by Aβ amyloid deposits in senile plaques (SP) and 
vessel walls. These Aβ amyloid deposits are associated 
with dystrophic neurites that show an accumulation of ab-
normally phosphorylated tau [2]. The Aβ amyloid in SP is 
derived from a larger amyloid precursor protein (APP), 
the gene of which is located on chromosome 21 [12]. Mu-
tations at codons 717 and 670/671 of the APP gene have 
been identified in familial early onset AD [5, 9, 23, 24]. 
APP mutations have been reported as rare genetic causes 
of presenile familial AD [30]. Most patients with APP 
mutations show a morphological picture that highly re-
sembles sporadic AD, although the severity of the mor-
phological changes is usually impressive [8, 13, 14, 19]. 
In one single family, a patient showed cortical Lewy bod-
ies in addition to neurofibrillary tangles (NFT) [16], while 
another showed a typical morphological picture of AD 
[4]. In hereditary cerebral hemorrhage with amyloidosis 
of the Dutch type (HCHWA-D) an APP mutation was 
identified at codon 693 replacing a glutamine for glutamic 
acid [17, 31]. In HCHWA-D, the neuropathological changes 
are dominated by the presence of an extensive congo-
philic amyloid angiopathy (CAA) [18]. SP are present in 
moderate numbers and are mostly of the diffuse or pre-
amyloid type [29]. Dystrophic, ubiquitin (Ub)-immunore-
active neurites have been demostrated in the corona of se-
nile plaques and in the parenchyma surrounding amy-
loidotic vessels, but are free from paired helical filaments 
(PHF) [27]. In sporadic forms of CAA, Ub-immunoreac-
tive and tau-negative neurites have also been observed 
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[26]. In fact, the absence of abnormally phosphorylated 
tau may be the reason why dystrophic neurites have not 
consistently been reported in HCHWA-D. We have re-
ported a APP mutation at codon 692 replacing a Gly for 
Ala [11]. In this Dutch family, also called family 1302, the 
clinical history is characterized by a progressive dementia 
indistinguishable from AD in some and intracerebral he-
morrhages in other patients. At the time our first report, 
only a single biopsy sample was available, of patient IV-
3, a 42-year-old woman who had suffered an intracerebral 
hemorrhage. In this biopsy specimen CAA was very promi-
nent, although numerous senile plaques were also de-
tected,with APP- and Ub-immunoreactive dystrophic neu-
rites. At the time of the hemorrhage, the patients’ cognitive 
status was unimpaired and no NFT were observed. Since 
then, she has developed a progressive dementia [33]. Since 
our first report, two patients of this family have died after 
suffering a progressive dementia, and brain autopsy was 
performed in both. The clinical findings in family 1302 will 
be reported separately (van Harskamp et al., in preparation). 
The present report concerns the neuropathological study of 
patients IV-6 and IV-2. Our morphological findings support 
the diagnosis of AD in both patients. Furthermore, this re-
port describes the neuropathological abnormalities, which 
are remarkable for the large amyloid core SP, the presence 
of NFT and an extensive amyloid angiopathy. 
Materials and methods 
Patients 
Case 1 
The patient was 48 years old when she first came to medical atten-
tion (individual IV-6 [11, 33]). She complained of increasing 
memory difficulties over a 2-year period, but was nevertheless 
able to manage her household and drive a car. Mental state exami-
nation showed slight disorientation and she appeared to confabu-
late. A CT scan of the brain was performed and showed no abnor-
malities. She developed a progressive dementia together with signs 
of a hypokinetic extrapyramidal syndrome. She was treated for a 
depression with vital signs. Four years after the onset of her de-
mentia, she was admitted to a nursing home, where she died of 
pneumonia at the age of 55. A diagnosis of probable AD was made 
according to NINCDS-ADRDA criteria [21]. 
Case 2 
Patient IV-2 was a man who showed memory disturbances at age 
49. He complained of frequent headaches and showed behavioral
disturbances. He subsequently showed language difficulties, con-
struction apraxia and dyscalculia. He died of pneumonia at the age 
of 57 years. 
Histopathology 
After fixation in 4% formaldehyde, the brains were cut into frontal 
sections which were examined macroscopically and photographed. 
Large cryosections were stained with the following techniques: 
Spielmeyer for myelin sheaths, Holzer for fibrillar glia, cresyl vio-
let stain for Nissl bodies, Sudan III for lipid breakdown products 
and periodic acid-Schiff for sugar residues. Paraffin blocks were 
stained with cresyl violet, hematoxylin eosin, Bodian, periodic 
acid-Schiff and with various mono- and polyclonal antibodies to: 
(1) Aβ amyloid 4G8 (courtesy of H. Wisniewski) [35]; (2) APP 
(22C11, Boehringer) [34]; (3) abnormally phosphorylated tau Ser 
202 (AT8, Innogenetics) [22]; (4) glial fibrillary acidic protein 
(GFAP; Dako); (5) ubiquitin (Novocastra and Dako); (6) microglia 
(HLA-DR, TAL1B5) (Dako), F14 [6] and CD68 (Dako); (7) phos-
phorylated neurofilaments [22]; and (8) prion protein (3F4, Senetek). 
Tissue fragments of the cerebellum superior frontal and tempo-
ral gyri, area striata and hippocampus were also fixed or post-fixed 
in glutaraldehyde followed by osmium tetroxide and embedded in 
Araldite for electron microscopy. 
Morphometric analysis was performed by digitizing images 
with a Sony camera mounted on a Reichert Polyvar microscope. 
The images were acquired with a Mass Microsystems frame grab-
ber and processed with a Macintosh fx computer. Measurements 
were performed with the public domain program Image version 
1.35 (courtesy of Wayne Rassband, NIH, Bethesda, Md.). The
amyloid core size of SP in the patients with the APP692 mutation 
was compared with the SP observed in one sporadic, late onset AD 
and three early onset familial AD patients with a presenilin-1 mu-
tation [7, 20]. A total of 140 SP were measured. 
Results 
Patient IV-2 
Macroscopic examination showed moderate cortical atro-
phy that predominated in the frontal lobes. The meninges 
Fig. 1 Small subcortical hemorrhage in the right insular region 
(arrow) 
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Fig. 2 A Numerous amyloid deposits and congophilic angiopathy 
in the neocortex (antibody 4G8 directed to Aβ amyloid). B Neu-
rofibrillary tangles are abundant in all neocortical locations. Detail 
of the superior temporal gyrus (immunostained with AT8, an anti-
body directed to phosphorylated serine 202 of the microtubule-as-
sociated protein tau. C Amyloid deposition in arterioles and 
dysoric angiopathy (4G8). D Typical large amyloid core senile 
plaques (4G8). E Large amyloid core senile plaques are sur-
rounded by a thin rim of dystrophic neurites (AT8). F Large amy-
loid core containing senile plaques in the Purkinje cell layer of the 
cerebellum (Nissl stain). A × 18; B × 53; C, D, F × 144; E × 93 
of the frontal and temporal lobes were thickened and 
showed brown discoloration. In the cortex and subcortical 
white matter, there were small cavities, which were often 
surrounded by a brownish hue (Fig. 1). Similar foci were 
found in the right putamen and the cerebellum. 
The superior frontal, superior temporal gyri and the 
area striata showed numerous leptomeningial vessels with 
amyloid deposits. Numerous hemosiderin-laden macro-
phages were also found in the leptomeninges. The under-
lying cortex showed moderate neuronal loss, superficial 
layer microspongiosis and reactive gliosis. In deeper cor-
tical layers, spongiosis was less pronounced, but there 
were some expanded perivascular spaces. SP of different 
types were present throughout the whole cortex. Large 
amyloid core, as well as neuritic and diffuse-type SP were 
observed. Amyloid deposits were also observed in arteri-
oles and capillaries. Some of these capillaries showed 
amyloid encroaching on the lumen, which was sometimes 
highly reduced in caliber. Neurofibrillary changes were 
more numerous in the superior temporal gyrus than in the 
other cortical locations. Spongiosis was most pronounced 
in the occipital area, where it also occurred in the white 
matter. In the entorhinal cortex, there was only mild neu-
ronal loss in layer II. Some of the pyramidal neurons con-
tained NFT. There were numerous diffuse and neuritic SP 
in the same region. The subiculum showed moderate neu-
ronal loss, numerous NFT and SP. In areas CA1 and CA2 
there was intense neuronal loss. In contrast, areas CA3 
and CA4 were relatively spared. Immunohistochemistry 
showed numerous 4G8 (Aβ )-immunoreactive amyloid de-
posits. Dystrophic neurites and NFT were immunoreac-
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tive with AT8, which also revealed numerous neuropil 
threads. The inferior temporal gyrus contained numerous 
NFT in pyramidal neurons. Microglia was intensely deco-
rated by antibodies to HLA-DR and CD68, while the re-
active astrocytes were GFAP immunoreactive. Less nu-
merous microglial cells were immunostained with F14. 
Subcortical structures showed fewer abnormalities. 
There were some SP in the nucleus caudatus, putamen 
and pallidum. The basal nucleus of Meynert showed mild 
neuronal loss and numerous SP. The putamen and right 
frontal subcortical white matter showed small cavities 
with rarefaction of myelin sheaths and numerous hemo-
siderin-laden macrophages. The thalamus showed a mod-
erate number of SP, mostly in the formatio medialis and 
nucleus ventralis oralis. 
The cerebellum showed moderate loss of Purkinje 
cells, thinning and spongiosis of the molecular layer. The 
dentate nucleus was normal. In the mesencephalon, some 
SP were found in the periaqueductal gray matter. The 
pons showed neuronal loss in the locus ceruleus and nu-
cleus raphe dorsalis. Some remaining neurons contained 
globose-type NFT. Cervical and dorsal spinal cord were 
normal. 
Patient IV-6 
General autopsy showed bilateral bronchopneumonia. 
The brain weighed 970 g and the substantia nigra was 
pale. Gross examination of the brain showed frontal and 
temporal cortical atrophy and compensatory widening of 
the lateral ventricles. Microscopic examination showed 
diffuse cortical atrophy with severe neuronal cell loss, dif-
fuse microspongiosis of the upper cortical layers and as-
trocytic gliosis. Lewy bodies were present in some sub-
stantia nigra neurons, but no cortical Lewy bodies were 
found in the limbic cortex or in the substantia innominata. 
Using cresyl violet staining, the walls of numerous blood 
vessels were seen to be thickened by metachromatic de-
posits. Large numbers of SP were observed in all isocorti-
cal gyri, the parahippocampal gyrus, amygdaloid nucleus, 
and hippocampus, while fewer were found in the neostria-
tum, thalamus, mesencephalic tectum and cerebellar cor-
tex (Fig. 2). Many cerebral cortical plaques were only 
constituted of a large amyloid core, while others were sur-
rounded by a meshwork of dystrophic neurites. The amy-
loid deposits were intensely stained by the monoclonal 
4G8 immunoreactive with Aβ (Fig. 2) and less intensely 
and less frequently with the monoclonal antibody to APP 
(22C11) (not shown). Numerous small vessels and capil-
laries showed accumulation of Aβ amyloid in the base-
ment membrane. Amyloid in the cortical and lep-
tomeningeal vessel walls was immunostained by the 4G8 
antibody. In the cerebellar cortex, SP were found in all 
cortical layers. 
These SP usually consisted of a large amyloid core 
without a disturbance of the surrounding parenchyma 
(Fig. 2). Their structure resembled kuru-type plaques, but 
they were definitely larger in size. In areas CA1 and CA2 
Fig. 3 Numerous neurofibrillary tangles and dystrophic neurites 
are immunostained by the monoclonal antibody AT8. × 245 
of the hippocampus, there was intense neuronal loss, 
while in areas CA3 and CA4 neuronal loss was less pro-
nounced. NFT were present in large numbers as shown 
with the AT8 antibody immunolabelling abnormally phos-
phorylated protein tau (Fig. 3). Extracellular NFT were 
extremely rare. Ub immunoreactivity was found in the cy-
toplasm of neurons and was only associated with NFT. No 
Lewy bodies could be demonstrated. Numerous astrocytes 
and microglia were present around the SP as shown by 
their GFAP and HLA-DR immunoreactivity, respectively 
(not shown). 
Immunocytochemistry for prion protein using the hy-
drated autoclave technique and monoclonal antibody 3F4 
was negative (not shown). 
Morphometry 
Two features of these large amyloid core SP were remark-
able. First, they constituted the majority of the SP. Second, 
the size of the amyloid core as compared to the total di-
ameter of the SP was exceedingly large (Figs. 4, 5). We 
Fig. 4 A, B Comparison of average amyloid core and total plaque 
size in the APP692 mutation and in AD. A The average diameter 
of amyloid core containing senile plaques in the APP692 mutation 
is 32 µ m, while the plaque core accounts for 48% of the plaque. B 
In contrast, similar plaques in chromosome 14-linked and sporadic 
AD patients measure on average 22 µ m, while the core accounts 
for 16% of the total plaque size (based on measurements of 140 
amyloid core containing senile plaques in 4 AD patients) (AD Alz-
heimer’s disease) 
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Fig. 5 Size histogram of the 
senile plaque cores in the 
APP692 mutation patients 
(APP692) as compared to spo-
radic and chromosome 14-
linked AD patients (C) 
compared the ratio of the area of the amyloid core to that 
of the total SP, both in the patients with the APP692 mu-
tation and in sporadic and familial AD cases. We found 
that the amyloid core in the APP692 mutation comprised 
on average 48 ± 17% of the total plaque, while the amy-
loid core in sporadic and chromosome 14-linked familial 
AD SP comprised on average only 16 ± 12% of the total 
plaque size (Fig. 4). The corona of amyloid core contain-
ing SP was small in comparison to the size of the core. 
Electron microscopy 
Electron microscopy on samples of the amygdaloid nu-
cleus, frontal, temporal and occipital cortices showed typ-
ical PHF in the neuronal perikarya. SP were mainly con-
stituted of large cores of amyloid deposits grouped in bun-
dles and with a radial distribution (Fig. 6 A). The amyloid 
core size often exceeded 30 µ m. These large amyloid 
cores existed in the neuropil or close to small blood ves-
sels. Microglial cells with debris including amyloid fila-
ments and lipofuscin bodies were often found in the 
neighborhood of amyloid deposits. The vessel walls were 
thickened and contained numerous amyloid filaments 
(Fig. 6 B). In some vessels, the amyloid was not confined 
to the vessel wall, but infiltrated the surrounding brain 
parenchyma. Associated with the basement membranes of 
some capillaries were large masses of amyloid, sometimes 
measuring 50 µ m in diameter. In the hippocampus, neu-
rons often contained PHF. Ghost tangles were associated 
with amyloid deposits, glial filaments and dystrophic neu-
rites. Granulovacuolar degeneration and a few Hirano 
bodies were also found in hippocampal neurons. Large 
core amyloid plaques were often surrounded by astrocytes 
or microglia. 
The cerebellum showed fewer abnormalities. The 
Purkinje cells were normal, but in the same layer, we ob-
served numerous large core amyloid SP, of which the di-
ameter ranged between 6 and 35 µ m. Intermingled among 
the amyloid fibrils were astrocytic extensions filled with 
intermediate filaments. Furthermore, dystrophic neurites 
were present, with numerous vesicles and amorphous 
dense structures, but no PHF. Very large perivascular 
Size (µ m2) 
Fig. 6 A Electron micrograph of the periphery of a senile plaque 
showing amyloid fibrils surrounded by dystrophic neurites in the 
frontal cortex. B Electron micrograph of a large dysoric amyloid 
deposit which spread radially from a vessel wall to the surrounding 
neuropil in the cerebellar cortex. Sections were fixed in glutaralde-
hyde, followed by postfixation in osmium tetroxide, embedding in 
Epon, and staining with uranyl acetate and lead citrate. Bars A, 
B 1 µ m 
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Table 1 Essential differences 
of clinical events and neu- APP692 HCHWA-D AD 
ropathological changes in 
APP692 mutation, hereditary 
cerebral hemorrhage with amy-
Amyloid angiopathy 
Number of senile plaques 
++++ 
++++ 
++++ 
++ 
++ 
++++ 
loidosis (HCHWA-D) and Alz- Diffuse-type SP Associated with capillaries Predominate Variable 
heimer’s disease (AD) (SP se-
nile plaque) 
Cerebellar SP 
Neurofibrillary tangles 
Large amyloid core 
Intracellular 
? 
Rare 
Mostly diffuse 
Intra- and extracellular 
Tau-immunoreactive ++++ – ++++ 
dystrophic neurites 
Dementia Progressive Vascular type Progressive 
Intracerebral hemorrhage Frequent Characteristic Rare 
amyloid depositions were also found associated with the 
basement membrane. Immediately surrounding amy-
loidotic capillaries were dystrophic neurites. 
Discussion 
We describe the neuropathological examination of the 
brains of two patients of family 1302: a 55-year-old 
woman and a 57-year-old man carrying the APP A692G 
mutation who were diagnosed with probable AD accord-
ing to NINCDS-ADRDA criteria. Examination of the 
brains showed lesions that fulfilled the neuropathological 
criteria for AD [15]. Cortical and subcortical neuronal 
loss was accompanied by the presence of numerous SP and 
congophilic angiopathy. However, the SP of the patients 
we report were clearly different from these found in clas-
sical AD, large core amyloid plaques being observed 
throughout the neocortex and cerebellum. In addition, 
there was very extensive amyloid angiopathy with large 
amyloid masses encroaching on the lumen of capillaries. 
Neuronal cell loss and the presence of Lewy bodies in the 
substantia nigra in patient IV-6 were probably related to 
her extrapyramidal symptoms. As there were no cortical 
Lewy bodies, it is likely that she suffered from coexistent 
Parkinson’s disease, rather than diffuse Lewy body dis-
ease or the diffuse Lewy body variant of AD. 
AD patients show a progressive dementia that is corre-
lated with an increase in the number of SP, NFT and 
synapse loss found at autopsy [28]. Most patients with 
HCHWA-D show a vascular-type dementia that is corre-
lated with the number of lesions observed on CT scan of 
the brain, although a few patients also show progressive 
dementia in the absence of intracerebral hemorrhage [3, 
10, 32]. Amyloid deposits are also found in normal aging, 
especially in the medial temporal lobes, and in HCHWA-
D, in the absence of dementia. In a biopsy specimen from 
the hemorrhagic stroke patient IV-3 carrying the APP692 
mutation that we examined previously [11], we observed 
numerous SP and extensive CAA, but no NFT. At the 
time of the biopsy, this patient was cognitively intact, but 
since then, she has developed a progressive dementia ful-
filling the criteria for probable AD [33]. 
The differences between the neuropathological abnor-
malities of early onset AD caused by the APP717 muta-
tion, APP693 causing HCHWA-D, and the presently de-
scribed patient with the APP692 mutation relate not only 
to the different phenotypes of amyloid deposits, but also 
to neurofibrillary pathology. In the patients we described 
in this report, a specific type of SP is associated with AD 
changes consisting of NFT, neuropil threads and neuritic 
plaques with dystrophic neurites containing abnormally 
phosphorylated tau. Therefore, it seems likely that the 
presenile dementia in this patient is related more to the 
presence of NFT and neuritic changes, than to the pres-
ence of amyloid deposits, which is sustained by the cog-
nitive intactness in patient IV-3. The essential differences 
of clinical events and neuropathological changes in 
APP692 mutation, HCHWA-D and AD are shown in 
Table 1. 
The pathogensis of Aβ amyloid deposits in SP and 
CAA and their relationship with NFT in AD is still a mat-
ter of considerable debate. Microglia, astrocytes, neurons 
and smooth muscle cells alike could be involved in the 
production and metabolism of APP leading to Aβ amyloid 
deposits [1, 25, 36]. While in AD, the APP717 mutation 
leads to the development of numerous NFT, these are 
strikingly absent from the brains of patients with the 
APP693 mutation in HCHWA-D. In contrast, in the 
APP692 mutation, extensive CAA is associated with the 
presence of numerous NFT. 
The site of the APP mutation apparently determines 
the location of Aβ amyloid deposition in cortex or vessel 
walls. The predominant type of Aβ amyloid that is de-
posited, be it Aβ 1-40 or Aβ 1-42(43), may also be influ-
enced by the presence and site of mutations. Lastly, APP 
mutations and their site could, either directly or indirectly, 
play a role in the susceptibility of neurons to develop 
NFT. This last hypothesis should be further examined in 
mutant APP transfected neuronal cell lines or transgenic 
animals. 
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